Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) CEO Sells 27,674 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CEO Jeff Shaner sold 27,674 shares of the company’s stock in a transaction that occurred on Wednesday, December 31st. The shares were sold at an average price of $8.18, for a total transaction of $226,373.32. Following the sale, the chief executive officer owned 2,423,536 shares in the company, valued at $19,824,524.48. The trade was a 1.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Jeff Shaner also recently made the following trade(s):

• On Friday, January 2nd, Jeff Shaner sold 29,357 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.85, for a total transaction of $230,452.45.
• On Tuesday, December 30th, Jeff Shaner sold 27,929 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.36, for a total transaction of $233,486.44.

Aveanna Healthcare Stock Performance

Shares of NASDAQ:AVAH traded down $0.09 during trading on Friday, hitting $8.08. 2,526,966 shares of the company were exchanged, compared to its average volume of 1,076,101. Aveanna Healthcare Holdings Inc. has a 52-week low of $3.67 and a 52-week high of $10.32. The stock has a 50 day moving average of $8.92 and a 200 day moving average of $7.49. The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23. The company has a market cap of $1.69 billion, a PE ratio of 22.44 and a beta of 2.06.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The company had revenue of $450.53 million during the quarter. As a group, equities research analysts predict that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current year.

Hedge Funds Weigh In On Aveanna Healthcare

A number of institutional investors have recently made changes to their positions in AVAH. Jump Financial LLC bought a new position in shares of Aveanna Healthcare during the first quarter valued at about $59,000. Walleye Capital LLC boosted its holdings in Aveanna Healthcare by 268.9% during the 1st quarter. Walleye Capital LLC now owns 51,470 shares of the company’s stock valued at $279,000 after acquiring an additional 37,517 shares during the period. MetLife Investment Management LLC grew its position in Aveanna Healthcare by 16.2% during the 1st quarter. MetLife Investment Management LLC now owns 31,251 shares of the company’s stock worth $169,000 after acquiring an additional 4,349 shares during the last quarter. AQR Capital Management LLC increased its stake in Aveanna Healthcare by 21.2% in the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock worth $142,000 after purchasing an additional 4,602 shares during the period. Finally, Banque Transatlantique SA purchased a new position in Aveanna Healthcare in the 1st quarter worth approximately $25,000. Institutional investors own 87.96% of the company’s stock.

Wall Street Analysts Forecast Growth

AVAH has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. raised shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and increased their price target for the stock from $6.00 to $10.00 in a report on Thursday, September 18th. Raymond James Financial reiterated an “outperform” rating and issued a $13.00 target price on shares of Aveanna Healthcare in a research note on Friday, December 5th. Truist Financial raised their price target on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a report on Friday, November 7th. UBS Group upped their price target on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the stock a “neutral” rating in a report on Friday, November 7th. Finally, Jefferies Financial Group increased their price objective on Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a research report on Tuesday, October 28th. Five research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, Aveanna Healthcare currently has a consensus rating of “Hold” and a consensus price target of $10.69.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.